Suppression of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD)-mediated aryl hydrocarbon receptor transformation and CYP1A1 induction by the phosphatidylinositol 3-kinase inhibitor 2-(4-morpholinyl)-8-phenyl-4H-1- benzopyran-4-one (LY294002)-Reference-Cited by-同舟云学术

Suppression of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD)-mediated aryl hydrocarbon receptor transformation and CYP1A1 induction by the phosphatidylinositol 3-kinase inhibitor 2-(4-morpholinyl)-8-phenyl-4H-1- benzopyran-4-one (LY294002)

Published:2000-09 Issue:5 Volume:60 Page:635-642
ISSN:0006-2952
Container-title:Biochemical Pharmacology
language:en
Short-container-title:Biochemical Pharmacology

Author:

Guo Meng,Joiakim Aby,Reiners John J.

Publisher

Elsevier BV

Subject

Pharmacology,Biochemistry

Reference33 articles.

1. The aryl hydrocarbon receptor complex;Hankinson;Annu Rev Pharmacol Toxicol,1995

2. Ah receptor signaling pathways;Schmidt;Annu Rev Cell Dev Biol,1996

3. Drug-metabolizing enzymes in ligand-modulated transcription;Nebert;Biochem Pharmacol,1994

4. Agonistic and antagonistic effects of α-naphthoflavone on dioxin receptor function;Wilhelmsson;J Biol Chem,1994

5. Substituted flavones as aryl hydrocarbon (Ah) receptor agonists and antagonists;Lu;Biochem Pharmacol,1996

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Modulation of aryl hydrocarbon receptor activity by tyrosine kinase inhibitors (ponatinib and tofacitinib);Archives of Biochemistry and Biophysics;2024-09

2. Endogenous regulation of the Akt pathway by the aryl hydrocarbon receptor (AhR) in lung fibroblasts;Scientific Reports;2021-11-30

3. Commentary: Usage of Mitogen-Activated Protein Kinase Small Molecule Inhibitors: More Than Just Inhibition!;Frontiers in Pharmacology;2018-08-20

4. Suppression of CYP1 members of the AHR response by pathogen-associated molecular patterns;Journal of Leukocyte Biology;2017-10-10

5. The hepatocyte growth factor antagonist NK4 inhibits indoleamine-2,3-dioxygenase expression via the c-Met-phosphatidylinositol 3-kinase-AKT signaling pathway;International Journal of Oncology;2016-04-14